KR940008678A - 주사용 메스나 액제 - Google Patents

주사용 메스나 액제 Download PDF

Info

Publication number
KR940008678A
KR940008678A KR1019930020576A KR930020576A KR940008678A KR 940008678 A KR940008678 A KR 940008678A KR 1019930020576 A KR1019930020576 A KR 1019930020576A KR 930020576 A KR930020576 A KR 930020576A KR 940008678 A KR940008678 A KR 940008678A
Authority
KR
South Korea
Prior art keywords
scalpel
liquid
injectable
injection
value
Prior art date
Application number
KR1019930020576A
Other languages
English (en)
Other versions
KR100364466B1 (ko
Inventor
엥겔 위르겐
볼프-호이스 엘리자베트
데커 볼프강
카뮤글리아 지안카를로
자우어비어 디터
Original Assignee
볼프강 메르크, 라이너 토이브너
아스타 메디카 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 볼프강 메르크, 라이너 토이브너, 아스타 메디카 아크티엔게젤샤프트 filed Critical 볼프강 메르크, 라이너 토이브너
Publication of KR940008678A publication Critical patent/KR940008678A/ko
Application granted granted Critical
Publication of KR100364466B1 publication Critical patent/KR100364466B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

pH값 7.5이상인 저장-안정성 주사용 메스나 액제 및 이의 제조방법이 기술되어 있다.

Description

주사용 메스나 액제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. pH값 7.5이상으로 조절되어짐을 특징으로 하는 주사용 메스나 액제.
  2. 알칼리 물질을 부가하여 메스나 액제의 pH값 7.5이상으로 조절함을 특징으로 하는, 주사용 메스나 액제의 제조방법.
  3. 옥스아자포스포린 처리의 요독증 부착용 예방용 약제의 제조를 위한 제1항에 따른 주사용 메스나 액제의 용도.
  4. 옥스아자포스포린의 부작용을 예방하기 위한, pH값 7.5이상인 주사용 메스나 액제로 이루어진 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930020576A 1992-10-08 1993-10-06 주사용메스나용액,이의제조방법및이를함유하는약제 KR100364466B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4233842.5 1992-10-08
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen

Publications (2)

Publication Number Publication Date
KR940008678A true KR940008678A (ko) 1994-05-16
KR100364466B1 KR100364466B1 (ko) 2003-01-29

Family

ID=6469925

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930020576A KR100364466B1 (ko) 1992-10-08 1993-10-06 주사용메스나용액,이의제조방법및이를함유하는약제

Country Status (28)

Country Link
US (2) US5728738A (ko)
EP (1) EP0591710B1 (ko)
JP (1) JP3636372B2 (ko)
KR (1) KR100364466B1 (ko)
CN (1) CN1071114C (ko)
AT (1) ATE139693T1 (ko)
AU (1) AU667129B2 (ko)
BR (1) BR9304151A (ko)
CA (1) CA2107961C (ko)
CZ (1) CZ284584B6 (ko)
DE (2) DE4233842A1 (ko)
DK (1) DK0591710T3 (ko)
EG (1) EG20308A (ko)
ES (1) ES2089661T3 (ko)
FI (1) FI111804B (ko)
GR (1) GR3020669T3 (ko)
HK (1) HK7397A (ko)
HR (1) HRP931267B1 (ko)
HU (1) HU217123B (ko)
IL (1) IL107187A (ko)
NO (1) NO303712B1 (ko)
NZ (1) NZ248873A (ko)
RU (1) RU2105550C1 (ko)
SI (1) SI9300525A (ko)
SK (1) SK279609B6 (ko)
TW (1) TW279131B (ko)
UA (1) UA26134C2 (ko)
ZA (1) ZA937458B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6031006A (en) * 1999-10-21 2000-02-29 Bionumerik Pharmaceuticals, Inc. Method of treating diabetic nephropathy
TW201036529A (en) 2009-03-25 2010-10-01 Askey Computer Corp A liquid crystal anti-freeze method and a liquid crystal module using the liquid crystal anti-freeze method
UA74097U (ru) * 2012-07-24 2012-10-10 Николай Иванович Гуменюк Способ изготовления средства для лечения туберкулеза
EP3597128A1 (en) 2013-05-07 2020-01-22 AuXin Surgery SA Device for chemically assisted dissection
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique
US20200289144A1 (en) 2016-03-14 2020-09-17 Auxin Surgery Sa Device, method and formulation for chemically assisted dissection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770A1 (de) * 1981-03-25 1982-10-07 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Verwendung von dimercaptopropansulfonsaeure und dimercaptobernsteinsaeure zur herstellung von pharmazeutischen mitteln
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.

Also Published As

Publication number Publication date
JP3636372B2 (ja) 2005-04-06
HU9302837D0 (en) 1993-12-28
US5696172A (en) 1997-12-09
NO933590L (no) 1994-04-11
DE4233842A1 (de) 1994-04-14
CN1089137A (zh) 1994-07-13
SK279609B6 (sk) 1999-01-11
AU4888393A (en) 1994-04-21
KR100364466B1 (ko) 2003-01-29
AU667129B2 (en) 1996-03-07
CZ284584B6 (cs) 1999-01-13
ATE139693T1 (de) 1996-07-15
EP0591710A1 (de) 1994-04-13
TW279131B (ko) 1996-06-21
ES2089661T3 (es) 1996-10-01
SI9300525A (en) 1994-06-30
DK0591710T3 (da) 1996-09-30
CZ209793A3 (en) 1994-04-13
BR9304151A (pt) 1994-06-07
IL107187A0 (en) 1994-01-25
HRP931267B1 (en) 1997-08-31
HRP931267A2 (en) 1994-12-31
IL107187A (en) 1999-03-12
GR3020669T3 (en) 1996-10-31
FI934410A0 (fi) 1993-10-07
JPH06263629A (ja) 1994-09-20
EP0591710B1 (de) 1996-06-26
CA2107961C (en) 2003-03-25
DE59303067D1 (de) 1996-08-01
HUT65096A (en) 1994-04-28
NO303712B1 (no) 1998-08-24
ZA937458B (en) 1994-04-26
CN1071114C (zh) 2001-09-19
NO933590D0 (no) 1993-10-07
FI111804B (fi) 2003-09-30
US5728738A (en) 1998-03-17
HU217123B (hu) 1999-11-29
FI934410A (fi) 1994-04-09
SK107993A3 (en) 1994-05-11
NZ248873A (en) 1995-10-26
HK7397A (en) 1997-01-24
RU2105550C1 (ru) 1998-02-27
EG20308A (en) 1998-10-31
CA2107961A1 (en) 1994-04-09
UA26134C2 (uk) 1999-06-07

Similar Documents

Publication Publication Date Title
PT92131A (pt) Processo para a preparacao de meios para aplicacao transdermicacontendo gestodeno
ES2047493T3 (es) Barrera y procedimiento de prevencion de la adhesion que contiene heparina.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
ATE275948T1 (de) Verwendung von adamantan derivaten zur herstellung eines medikaments zur glaukombehandlung
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
KR890011606A (ko) 항응고제
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
KR940008678A (ko) 주사용 메스나 액제
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
DE69727811D1 (de) Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
DE69825887D1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
KR890011589A (ko) 벤즈아미드의 용도
KR890000097A (ko) 항레트로비루스 작용을 갖는 당단백질 처리 억제제
KR880013555A (ko) 당뇨병의 치료방법
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
ATE75144T1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
KR880002527A (ko) 신경변질 치료용 안 조성물
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
KR880003211A (ko) 콘택트 렌즈의 처리 방법
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
AMND Amendment
B601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010414

Effective date: 20020730

S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121107

Year of fee payment: 11

EXPY Expiration of term